ATE357253T1 - Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten - Google Patents

Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten

Info

Publication number: ATE357253T1
Authority: AT; Austria
Prior art keywords: antigen; protein; respiratory; synzytial; viruse
Prior art date: 2001-12-20

Application number

AT02784987T

Other languages

English (en)

Inventor

Brian Barber

George Cates

Mark Parrington

Suryprakash Sambhara

Original Assignee

Aventis Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2002-12-18

Publication date

2007-04-15

2002-12-18 Application filed by Aventis Pasteur filed Critical Aventis Pasteur

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE357253T1 publication Critical patent/ATE357253T1/de

Links

239000000427 antigen Substances 0.000 title abstract 6
102000036639 antigens Human genes 0.000 title abstract 6
108091007433 antigens Proteins 0.000 title abstract 6
239000000203 mixture Substances 0.000 title abstract 3
230000002163 immunogen Effects 0.000 title abstract 2
241000700605 Viruses Species 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
230000000241 respiratory effect Effects 0.000 title 1
241000725643 Respiratory syncytial virus Species 0.000 abstract 3
230000028993 immune response Effects 0.000 abstract 3
101710085938 Matrix protein Proteins 0.000 abstract 1
101710127721 Membrane protein Proteins 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AT02784987T 2001-12-20 2002-12-18 Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten ATE357253T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US34142201P	2001-12-20	2001-12-20

Publications (1)

Publication Number	Publication Date
ATE357253T1 true ATE357253T1 (de)	2007-04-15

Family

ID=23337497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02784987T ATE357253T1 (de)	2001-12-20	2002-12-18	Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten

Country Status (9)

Country	Link
US (1)	US20050037015A1 (de)
EP (1)	EP1409014B8 (de)
AT (1)	ATE357253T1 (de)
AU (1)	AU2002350342A1 (de)
CA (1)	CA2436972A1 (de)
DE (1)	DE60219021T2 (de)
DK (1)	DK1409014T3 (de)
ES (1)	ES2283614T3 (de)
WO (1)	WO2003053464A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6020182A (en) *	1996-07-12	2000-02-01	Connaught Laboratories Limited	Subunit respiratory syncytial virus vaccine preparation
ATE234631T1 (de) *	1996-07-12	2003-04-15	Aventis Pasteur	Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten
GB9726555D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Vaccine

2002
- 2002-12-18 DK DK02784987T patent/DK1409014T3/da active
- 2002-12-18 EP EP02784987A patent/EP1409014B8/de not_active Expired - Lifetime
- 2002-12-18 WO PCT/CA2002/001953 patent/WO2003053464A1/en not_active Ceased
- 2002-12-18 AU AU2002350342A patent/AU2002350342A1/en not_active Abandoned
- 2002-12-18 US US10/467,828 patent/US20050037015A1/en not_active Abandoned
- 2002-12-18 AT AT02784987T patent/ATE357253T1/de active
- 2002-12-18 DE DE60219021T patent/DE60219021T2/de not_active Expired - Lifetime
- 2002-12-18 ES ES02784987T patent/ES2283614T3/es not_active Expired - Lifetime
- 2002-12-18 CA CA002436972A patent/CA2436972A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20050037015A1 (en)	2005-02-17
EP1409014A1 (de)	2004-04-21
EP1409014B1 (de)	2007-03-21
EP1409014B8 (de)	2007-04-25
WO2003053464A1 (en)	2003-07-03
ES2283614T3 (es)	2007-11-01
AU2002350342A1 (en)	2003-07-09
DK1409014T3 (da)	2007-07-30
DE60219021D1 (de)	2007-05-03
CA2436972A1 (en)	2003-07-03
DE60219021T2 (de)	2007-12-13

Similar Documents

Publication	Publication Date	Title
DK1090033T3 (da)	2005-04-25	Partikler af HCV-kappeproteiner: Anvendelse til vaccination
IS8374A (is)	2006-03-27	Bóluefnissamsetningar sem samanstanda af hvítfrumuboða 18 og sapónín ónæmisglæðakerfi
WO2008057529A3 (en)	2008-12-24	Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
BR0116026A (pt)	2004-12-21	Imidazoquinolinas substituìdas por tioéter
ZA200409186B (en)	2005-10-26	Specific antibodies to amyloid beta peptide, pahrmaceutical compositions and methods of use thereof.
RS20120139A3 (en)	2015-02-27	8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
TW200618817A (en)	2006-06-16	Diffractive colorants for cosmetics
UA103751C2 (ru)	2013-11-25	Иммуногенный пептид для иммунотерапии
PL378107A1 (pl)	2006-03-06	1,2,4-triazyny hamujące HIV
WO2009060281A3 (en)	2009-08-13	Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
DE60228971D1 (de)	2008-10-30	Peptide aus dem g-protein des respiratorischen synzytialvirus und deren verwendung in einem impfstoff
AU2003246373A8 (en)	2004-01-06	Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
BR0109164A (pt)	2002-11-26	Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
ATE357253T1 (de)	2007-04-15	Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten
DE60131975D1 (de)	2008-01-31	Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
TW200509964A (en)	2005-03-16	VP1 of foot-and-mouth disease virus
DE50304242D1 (de)	2006-08-24	Verfahren zur herstellung von acylphosphinoxiden
AU7522401A (en)	2001-12-17	Non-agonistic antibodies to human gp39, compositions containing, and therapeuticuse thereof
DE60139633D1 (de)	2009-10-01	Transformierender wachstumsfaktor alpha enthaltende impfstoffzusammensetzung
DE60223564D1 (de)	2007-12-27	Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
MX2007002659A (es)	2007-05-16	Composicion vacunal contra el virus de la hepatitis c.
WO2004092207A3 (en)	2005-04-07	Respiratory syncytial virus (rsv) peptides
ATE353226T1 (de)	2007-02-15	Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
DK1553979T3 (da)	2007-12-27	IHNV-G-fusionsprotein til immunistimulering
ATE385809T1 (de)	2008-03-15	Saponin-zusammensetzungen und deren verwendung

Legal Events

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1409014

Country of ref document: EP